5 research outputs found
ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΏΡΠΎΡΠ΅ΠΊΡΠΈΠ²Π½ΡΡ ΡΠ²ΠΎΠΉΡΡΠ² ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ° Π±Π΅Π»ΠΊΠ° F Π½Π°ΡΡΠΆΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Ρ ΠΈ Π°Π½Π°ΡΠΎΠΊΡΠΈΠ½Π° Pseudomonas aeruginosa
Pseudomonas aeruginosa induces the complications after burns, injuries, surgical interventions and appears to be one of the main causative agents of nosocomial infections. This pathogen has the high resistance to the antibacterial preparations, therefore the immunoprophylaxis is considered as one of the major approaches to reduce Pseudomonas infection. Objective: The aim of our investigation is to study the protective properties of the recombinant complex of the outer membrane protein F (OprF) and a non-toxic variant of the exotoxin A (toxoid) against Pseudomonas infection. Methods: The recombinant proteins which contained the additional histidine residues were synthesized into Escherichia coli with isopropyl-Ξ²D-thyogalactopyranoside (IPTG). The recombinant proteins were purified by affinity chromatography on Ni-Sepharose. The preparations of recombinant proteins were injected intraperitoneally into the mice. Aluminum hydroxide was used as an adjuvant. For an experimental infection in mice, animals were challenged intraperitoneally by a live virulent culture of P. aeruginosa (PA-103 strain). Results: The best protective effect for the complex containing 25 ΞΌg OprF and 50 ΞΌg toxoid was identified when we used the double immunization of mice (Index of efficiency of the protective properties in this case was 4.0). Indexes of efficiency of separated recombinant proteins which were injected twice in the same doses were 2.0 for OprF ΠΈ 2.3 for toxoid. The triple immunization of animals was inefficient for separated recombinant proteins in the same doses. The injection of doses which were lowered twice (12.5 ΞΌg for OprF and 25 ΞΌg for toxoid) resulted in increased survival of mice immunized by individual proteins (indexes of efficiency: 3 for OprF and ΠΈ 3,5 for toxoid). However when we administered to the complex of proteins with the same doses Index of efficiency was 2.8. Conclusion: It was shown that the maximum protective effect in a short time is achieved by the combination of double immunization and the mixture of the recombinant proteins OprF and the 25 and 50 ΞΌg doses of recombinant toxoid .Β Pseudomonas aeruginosa Π²ΡΠ·ΡΠ²Π°Π΅Ρ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ ΠΏΠΎΡΠ»Π΅ ΠΎΠΆΠΎΠ³ΠΎΠ², ΡΡΠ°Π²ΠΌ ΠΈ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
Π²ΠΌΠ΅ΡΠ°ΡΠ΅Π»ΡΡΡΠ², ΡΠ²Π»ΡΡΡΡ ΠΎΠ΄Π½ΠΎΠΉ ΠΈΠ· ΠΎΡΠ½ΠΎΠ²Π½ΡΡ
ΠΏΡΠΈΡΠΈΠ½ Π½ΠΎΠ·ΠΎΠΊΠΎΠΌΠΈΠ°Π»ΡΠ½ΡΡ
ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΉ. ΠΡΠΎΡ ΠΏΠ°ΡΠΎΠ³Π΅Π½ ΠΎΠ±Π»Π°Π΄Π°Π΅Ρ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΡΡ ΠΊ Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Ρ Π°Π½ΡΠΈΠ±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΡ
ΡΡΠ΅Π΄ΡΡΠ², ΠΏΠΎΡΡΠΎΠΌΡ ΠΈΠΌΠΌΡΠ½ΠΎΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠ° ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡΡΡ ΠΊΠ°ΠΊ ΠΎΠ΄ΠΈΠ½ ΠΈΠ· ΠΏΡΠΈΠΎΡΠΈΡΠ΅ΡΠ½ΡΡ
ΠΏΠΎΠ΄Ρ
ΠΎΠ΄ΠΎΠ² Π΄Π»Ρ Π±ΠΎΡΡΠ±Ρ Ρ ΡΠΈΠ½Π΅Π³Π½ΠΎΠΉΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ. Π¦Π΅Π»Ρ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ: ΠΠ·ΡΡΠΈΡΡ Π·Π°ΡΠΈΡΠ½ΡΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΠΎΠ³ΠΎ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ° Π±Π΅Π»ΠΊΠ° F Π½Π°ΡΡΠΆΠ½ΠΎΠΉ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Ρ (OprF) ΠΈ Π°ΡΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠΎΡΠΌΡ ΡΠΊΠ·ΠΎΡΠΎΠΊΡΠΈΠ½Π°Β Π (Π°Π½Π°ΡΠΎΠΊΡΠΈΠ½Π°) ΠΎΡ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΉ ΡΠΈΠ½Π΅Π³Π½ΠΎΠΉΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ. ΠΠ΅ΡΠΎΠ΄Ρ: Π Π΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΠ΅ Π±Π΅Π»ΠΊΠΈ, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΠ΅ Π΄ΠΎΠΏΠΎΠ»Π½ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΡΠ΅ΡΡΠΈ Π³ΠΈΡΡΠΈΠ΄ΠΈΠ½ΠΎΠ²ΡΡ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΡ, ΡΠΈΠ½ΡΠ΅Π·ΠΈΡΠΎΠ²Π°Π»ΠΈ Π² ΠΊΠ»Π΅ΡΠΊΠ°Ρ
Escherichia coli c ΠΏΠΎΠΌΠΎΡΡΡ ΠΈΠ·ΠΎΠΏΡΠΎΠΏΠΈΠ»-b-d-ΡΠΈΠΎΠ³Π°Π»Π°ΠΊΡΠΎΠΏΠΈΡΠ°Π½ΠΎΠ·ΠΈΠ΄Π° (ΠΠΠ’Π) ΠΈ ΠΎΡΠΈΡΠ°Π»ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π°ΡΡΠΈΠ½Π½ΠΎΠΉ Ρ
ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΠΈ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Ni-ΡΠ΅ΡΠ°ΡΠΎΠ·Ρ. ΠΡΠ΅ΠΏΠ°ΡΠ°ΡΠ°ΠΌΠΈ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΡ
Π±Π΅Π»ΠΊΠΎΠ² Π²Π½ΡΡΡΠΈΠ±ΡΡΡΠΈΠ½Π½ΠΎ ΠΈΠΌΠΌΡΠ½ΠΈΠ·ΠΈΡΠΎΠ²Π°Π»ΠΈ ΠΌΡΡΠ΅ΠΉ. Π ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ Π°Π΄ΡΡΠ²Π°Π½ΡΠ° ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π»ΠΈ Π³ΠΈΠ΄ΡΠΎΠΊΡΠΈΠ΄ Π°Π»ΡΠΌΠΈΠ½ΠΈΡ. ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠ΅ Π·Π°ΡΠ°ΠΆΠ΅Π½ΠΈΠ΅ ΠΎΡΡΡΠ΅ΡΡΠ²Π»ΡΠ»ΠΈ Π²Π½ΡΡΡΠΈΠ±ΡΡΡΠΈΠ½Π½ΡΠΌ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ΠΌ ΠΆΠΈΠ²ΠΎΠΉ Π²ΠΈΡΡΠ»Π΅Π½ΡΠ½ΠΎΠΉ ΠΊΡΠ»ΡΡΡΡΡ P.Β aeruginosa ΡΡΠ°ΠΌΠΌΠ° Π Π103. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ: ΠΡΠΈ Π΄Π²ΡΠΊΡΠ°ΡΠ½ΠΎΠΉ ΠΈΠΌΠΌΡΠ½ΠΈΠ·Π°ΡΠΈΠΈ ΠΌΡΡΠ΅ΠΉ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠΎΠΌ, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΠΌ 25 ΠΌΠΊΠ³ OprF ΠΈ 50 ΠΌΠΊΠ³ Π°Π½Π°ΡΠΎΠΊΡΠΈΠ½Π°, Π²ΡΡΠ²Π»Π΅Π½ Π½Π°ΠΈΠ»ΡΡΡΠΈΠΉ ΠΏΡΠΎΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΉ ΡΡΡΠ΅ΠΊΡ (ΠΈΠ½Π΄Π΅ΠΊΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π·Π°ΡΠΈΡΠ½ΡΡ
ΡΠ²ΠΎΠΉΡΡΠ² Π² ΡΡΠΎΠΌ ΡΠ»ΡΡΠ°Π΅ ΡΠΎΡΡΠ°Π²ΠΈΠ» 4,0). ΠΠ½Π΄Π΅ΠΊΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π΄Π»Ρ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΡ
Π±Π΅Π»ΠΊΠΎΠ², Π²Π²ΠΎΠ΄ΠΈΠΌΡΡ
Π΄Π²ΡΠΊΡΠ°ΡΠ½ΠΎ Π² ΡΠ΅Ρ
ΠΆΠ΅ Π΄ΠΎΠ·Π°Ρ
ΠΏΠΎ ΠΎΡΠ΄Π΅Π»ΡΠ½ΠΎΡΡΠΈ, ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΎΠ²Π°Π»ΠΈ 2,0 Π΄Π»Ρ OprF ΠΈ 2,3 Π΄Π»Ρ Π°Π½Π°ΡΠΎΠΊΡΠΈΠ½Π° ΠΈ Π½Π΅ ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°Π»ΠΈΡΡ ΠΏΠΎΡΠ»Π΅ ΡΡΠ΅Ρ
ΠΊΡΠ°ΡΠ½ΠΎΠΉ ΠΈΠΌΠΌΡΠ½ΠΈΠ·Π°ΡΠΈΠΈ ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
. Π£ΠΌΠ΅Π½ΡΡΠ΅Π½Π½ΡΠ΅ Π² Π΄Π²Π° ΡΠ°Π·Π° Π΄ΠΎΠ· (12,5 ΠΌΠΊΠ³ OprF ΠΈ 25 ΠΌΠΊΠ³ Π°Π½Π°ΡΠΎΠΊΡΠΈΠ½Π°) ΠΏΡΠΈ ΡΡΠ΅Ρ
ΠΊΡΠ°ΡΠ½ΠΎΠΌ Π²Π²Π΅Π΄Π΅Π½ΠΈΠΈ ΡΠΏΠΎΡΠΎΠ±ΡΡΠ²ΠΎΠ²Π°Π»ΠΎ ΡΠ²Π΅Π»ΠΈΡΠ΅Π½ΠΈΡ Π²ΡΠΆΠΈΠ²Π°Π΅ΠΌΠΎΡΡΠΈ ΠΌΡΡΠ΅ΠΉ ΠΈΠΌΠΌΡΠ½ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΠΌΠΈ Π±Π΅Π»ΠΊΠ°ΠΌΠΈ (ΠΈΠ½Π΄Π΅ΠΊΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ: 3 Π΄Π»Ρ OprF ΠΈ 3,5 Π΄Π»Ρ Π°Π½Π°ΡΠΎΠΊΡΠΈΠ½Π°), ΠΎΠ΄Π½Π°ΠΊΠΎ ΠΏΡΠΈ Π²Π²Π΅Π΄Π΅Π½ΠΈΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ° Π±Π΅Π»ΠΊΠΎΠ² Π² ΡΠ΅Ρ
ΠΆΠ΅ Π΄ΠΎΠ·Π°Ρ
ΠΈΠ½Π΄Π΅ΠΊΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ Π½Π΅ ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°Π»ΡΡ ΠΈ ΡΠΎΡΡΠ°Π²ΠΈΠ» 2,8. ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅: ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΡΠΉ ΠΏΡΠΎΡΠ΅ΠΊΡΠΈΠ²Π½ΡΠΉ ΡΡΡΠ΅ΠΊΡ ΡΠΎΡΠΌΠΈΡΡΠ΅ΡΡΡ Π² ΠΊΠΎΡΠΎΡΠΊΠΈΠ΅ ΡΡΠΎΠΊΠΈ ΠΏΡΠΈ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠΉ ΠΈΠΌΠΌΡΠ½ΠΈΠ·Π°ΡΠΈΠΈ Π΄Π²ΡΠΌΡ ΡΠ΅ΠΊΠΎΠΌΠ±ΠΈΠ½Π°Π½ΡΠ½ΡΠΌΠΈ Π±Π΅Π»ΠΊΠ°ΠΌΠΈ OprF ΠΈ Π°Π½Π°ΡΠΎΠΊΡΠΈΠ½ΠΎΠΌ Π² Π΄ΠΎΠ·Π°Ρ
25 ΠΈ 50 ΠΌΠΊΠ³
The hydrodynamic and conformational properties of poly-p-phenyleneoxadiazole in solutions
Management of adherence-based treatment. Consensus document β Clinical guidelines. English version [ΡΠΏΠ ΠΠΠΠΠΠΠ ΠΠΠ§ΠΠΠΠΠ ΠΠ ΠΠ‘ΠΠΠΠ ΠΏΠ ΠΠΠΠ ΠΠΠΠΠΠ‘Π’Π. ΠΠΠΠ‘ΠΠΠ‘ΡΠ‘ΠΠ«ΠΉ ΠΠΠΡΠΠΠΠ’ β ΠΠΠΠΠΠ§ΠΠ‘ΠΠΠ Π ΠΠΠΠΠΠΠΠΠ¦ΠΠ. ΠΠΠΠΠΠ―Π·Π«Π§ΠΠΠ― ΠΠΠ Π‘ΠΠ―]
Consensus Document Β«Management of adherence-based treatmentΒ» developed based on clinical guidelines of Russian Scientific Medical Society of Internal Medicine approved by the XIV National Congress of physicians (Moscow, 20 November 2019). The document is intended primarily to assess adherence to drug therapy, adherence to lifestyle modification, and adherence to medical support for patients who need long-term or permanent treatment. The documentβs authors considered the treatment adherence unanimously as the compliance of the patientβs behavior with the recommendations received from the Doctor regarding medication, dieting, and other measures of lifestyle modifications. Insufficient adherence to treatment is a global problem. Assessing adherence as a basis for making medical decisions is an essential element of improving the quality of the healthcare system. Predictions of treatment outcomes cannot be considered effective if individualized levels of adherence are not used to justify project planning and evaluation. In medical practice, quantitative assessment of adherence is preferred, suitable for patients with various diseases, and with the possibility of automated data entry and processing. Therefore, sections on medical interventions based on the assessment of treatment adherence should be reflected in national clinical guidelines. These Joint Recommendations are based on these provisions. Β© Group of authors, 202
Treatment management based on adherence: Patient recommendation algorithms. Cross-disciplinary guidelines [Π£ΠΠ ΠΠΠΠΠΠΠ ΠΠΠ§ΠΠΠΠΠ ΠΠ ΠΠ‘ΠΠΠΠ ΠΠ ΠΠΠΠ ΠΠΠΠΠΠ‘Π’Π: ΠΠΠΠΠ ΠΠ’ΠΠ« Π ΠΠΠΠΠΠΠΠΠ¦ΠΠ ΠΠΠ― ΠΠΠ¦ΠΠΠΠ’ΠΠ. ΠΠΠΠΠΠ‘Π¦ΠΠΠΠΠΠΠ ΠΠ«Π Π ΠΠΠΠΠΠΠΠΠ¦ΠΠ]
The algorithms (sample templates) of recommendations for patients, which are an integral part of adherence-based treatment management technologies, were developed by an interdisciplinary Working Group coordinated by the Treatment Adherence Section of the Russian Scientific Medical Society of Physicians. The Working Group includes opinion leaders and experts in the therapeutic, gastroenterology, cardiology, preventive medicine, gerontology, oncology, hematology, immunology, phthisiopulmonology, infectious diseases, oncohematology, neurology, intensive care, rehabilitation and other specialties, both involved by the section of RSMSIM, and recommended by the Gastroenterological Scientific Society of Russia, National Association of experts in Thrombosis, Clinical Hemostasiology and Hemorheology, Gerontological Society of the Russian Academy of Sciences, Russian Oncohematologists Society, Russian Society of Phthisiatrists, Society of Evidence-based Neurology. The algorithms are based on the materials of Β«The First Russian Consensus on Quantitative Assessment of adherence to treatmentΒ», approved by the XII National Congress of Internal Medicine (2017) and Clinical Guidelines Β«Treatment Management on the Basis of adherenceΒ», approved by the XIV National Congress of Internal Medicine (2019), taking into account the Consenting Document - Interdisciplinary Guidelines of RSMSIM, GSSR, NATH, SEN, GSRAS, ROHS, RSP Β«Treatment Management on the Basis of AdherenceΒ» (2020). The algorithms of treatment strategies are recommended by the Working Group to be used as a basis for inclusion into relevant sections of clinical guidelines and clinical handbooks developed by professional medical communities, as well as for use by practitioners in medical practice. Β© 2020 Stavropol State Medical University. All rights reserved